Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP529626.RADsr0Zdvvs2Gc_jLh-uvuL0t7aoOirhaLyVzM_HZXNNo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP529626.RADsr0Zdvvs2Gc_jLh-uvuL0t7aoOirhaLyVzM_HZXNNo130_assertion type Assertion NP529626.RADsr0Zdvvs2Gc_jLh-uvuL0t7aoOirhaLyVzM_HZXNNo130_head.
- NP529626.RADsr0Zdvvs2Gc_jLh-uvuL0t7aoOirhaLyVzM_HZXNNo130_assertion description "[These were compared with 2 other molecules that have been previously studied in thyroid cancer (cytokeratin-19 and galectin-3).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP529626.RADsr0Zdvvs2Gc_jLh-uvuL0t7aoOirhaLyVzM_HZXNNo130_provenance.
- NP529626.RADsr0Zdvvs2Gc_jLh-uvuL0t7aoOirhaLyVzM_HZXNNo130_assertion evidence source_evidence_literature NP529626.RADsr0Zdvvs2Gc_jLh-uvuL0t7aoOirhaLyVzM_HZXNNo130_provenance.
- NP529626.RADsr0Zdvvs2Gc_jLh-uvuL0t7aoOirhaLyVzM_HZXNNo130_assertion SIO_000772 18261626 NP529626.RADsr0Zdvvs2Gc_jLh-uvuL0t7aoOirhaLyVzM_HZXNNo130_provenance.
- NP529626.RADsr0Zdvvs2Gc_jLh-uvuL0t7aoOirhaLyVzM_HZXNNo130_assertion wasDerivedFrom befree-20150227 NP529626.RADsr0Zdvvs2Gc_jLh-uvuL0t7aoOirhaLyVzM_HZXNNo130_provenance.
- NP529626.RADsr0Zdvvs2Gc_jLh-uvuL0t7aoOirhaLyVzM_HZXNNo130_assertion wasGeneratedBy ECO_0000203 NP529626.RADsr0Zdvvs2Gc_jLh-uvuL0t7aoOirhaLyVzM_HZXNNo130_provenance.